Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
294.35
-30.05 (-9.26%)
BSENSE

Aug 10

BSE+NSE Vol: 12.49 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000007,
    "name": "Advanced Enzyme",
    "stock_name": "Advanced Enzyme",
    "full_name": "Advanced Enzyme Technologies Ltd",
    "name_url": "stocks-analysis/advanced-enzyme",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "294.35",
    "chg": -30.05,
    "chgp": "-9.26%",
    "dir": -1,
    "prev_price": "324.40",
    "mcapval": "3,450.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 540025,
    "symbol": "ADVENZYMES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE837H01020",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "12.49 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/advanced-enzyme-1000007-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Advanced Enzyme Technologies Ltd Shows Bullish Momentum Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/advanced-enzyme-technologies-ltd-shows-bullish-momentum-amid-technical-upgrades-4002187",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AdvancedEnzymeT_technicaldot_4002187.png",
        "date": "2026-05-21 08:03:48",
        "description": "Advanced Enzyme Technologies Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The company’s stock, currently trading at ₹387.90, has seen a positive day change of 0.57%, reflecting growing investor confidence amid improving technical signals and a recent upgrade in its Mojo Grade from Sell to Hold."
      },
      {
        "title": "Golden Cross Confirmed: Do Advanced Enzyme Technologies Ltd's Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/advanced-enzyme-technologies-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4001416",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AdvancedEnzymeT_goldencross_4001416.png",
        "date": "2026-05-20 18:00:34",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Advanced Enzyme Technologies Ltd, signalling a golden cross on 20 May 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination."
      }
    ],
    "total": 15,
    "sid": "1000007",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/advanced-enzyme-technologies-1000007"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On August 08 2026",
      "datetime": "08-Aug-2026",
      "details": "1) Approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "08-Aug-2026",
      "details": "Press Release titled Quaterly Earnings Release dated August 08 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "08-Aug-2026",
      "details": "1) Approved acquistion of the remaining stake of 4.28% Equity Shares from the other existing Equity Shareholders of JC Biotech Private Limited (Exisitng Subsidiary) and 2) Approved infusion of additional funds of Rs. 20 million in one or more tranches in Advanced Nutrazyme Private Limited (Wholly Owned Subsidiary) of the Company",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Advanced Enzyme Technologies Ltd has declared <strong>67%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Advanced Enzyme Technologies Ltd has announced <strong>2:10</strong> stock split, ex-date: 25 May 17",
          "dt": "2017-05-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of Board Meeting Held On August 08 2026

08-Aug-2026 | Source : BSE

1) Approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026

Announcement under Regulation 30 (LODR)-Press Release / Media Release

08-Aug-2026 | Source : BSE

Press Release titled Quaterly Earnings Release dated August 08 2026

Announcement under Regulation 30 (LODR)-Acquisition

08-Aug-2026 | Source : BSE

1) Approved acquistion of the remaining stake of 4.28% Equity Shares from the other existing Equity Shareholders of JC Biotech Private Limited (Exisitng Subsidiary) and 2) Approved infusion of additional funds of Rs. 20 million in one or more tranches in Advanced Nutrazyme Private Limited (Wholly Owned Subsidiary) of the Company

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Advanced Enzyme Technologies Ltd has declared 67% dividend, ex-date: 24 Jul 26

stock-summary
SPLITS

Advanced Enzyme Technologies Ltd has announced 2:10 stock split, ex-date: 25 May 17

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available